CXCL12 and neoplasm: In a preclinical mouse model of PDAC, it was demonstrated that CAFs that express the fibroblast activation protein (FAP) within the ECM produce and secrete CXCL12, which in turn binds to the PDAC tumor cells, coating them (241).